LM

Laxman Matai

Active Director Director DIN 00859538
DIN 00859538 First appointment Apr 2007 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2007
Shareholding value •••• Premium profile

About Laxman Matai

Data last updated:

Laxman Matai is a Director at Allied Healthsciences Private Limited (since 2007). The company operates in Healthcare. Allied Healthsciences Private Limited reported revenue of ₹2.02 Cr (FY 2024).

DIN 00859538
Primary Designation Director
Industry Healthcare
First Appointment 20 Apr 2007
Oldest Company Age 19 yrs
Largest company Allied Healthsciences Private Limited · ₹2.02 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Apr 20072007₹2.02 Cr (FY 2024)Active

Board colleagues of Laxman Matai

Directorship timeline

Open interactive timeline →
Allied Healthsciences Private Limited
Premium access

Shareholding and investment profile for Laxman Matai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Laxman Matai

Laxman Matai currently holds 1 directorship: Allied Healthsciences Private Limited (Director, since 20 Apr 2007, revenue ₹2.02 Cr (FY 2024)).

Laxman Matai was first appointed on 20 Apr 2007 as Director at Allied Healthsciences Private Limited.

The current boards of Laxman Matai's companies include Amitabh Majumdar (Allied Healthsciences Private Limited), Rajiv Gupta (Allied Healthsciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available